Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Hemostatic Agents market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Hemostatic Agents market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Hemostatic Agents market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Hemostatic Agents products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Hemostatic Agents products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Hemostatic Agents market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Hemostatic Agents development has been the leading industry trend of Hemostatic Agents market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Hemostatic Agents Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others |
| By Application Outlook |
Hospitals, Surgical Centers, Nursing Homes, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, CryoLife, BioCer Entwicklungs, Biom�Up SAS |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Ethicon
- Pfizer
- Baxter International
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences
- B Braun Melsungen
- Gelita Medical
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica
- CryoLife
- BioCer Entwicklungs
- Biom�Up SAS
Hemostatic Agents Market, By Type
- Gelation Sponge
- Oxidized Regenerated Cellulose Based Hemostats
- Others
Hemostatic Agents Market, By Application
- Hospitals
- Surgical Centers
- Nursing Homes
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Chapter 1 Hemostatic Agents Market Overview
1.1 Hemostatic Agents Definition
1.2 Global Hemostatic Agents Market Size Status and Outlook (2014-2026)
1.3 Global Hemostatic Agents Market Size Comparison by Region (2014-2026)
1.4 Global Hemostatic Agents Market Size Comparison by Type (2014-2026)
1.5 Global Hemostatic Agents Market Size Comparison by Application (2014-2026)
1.6 Global Hemostatic Agents Market Size Comparison by Sales Channel (2014-2026)
1.7 Hemostatic Agents Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Hemostatic Agents Market Segment Analysis by Player
2.1 Global Hemostatic Agents Sales and Market Share by Player (2017-2019)
2.2 Global Hemostatic Agents Revenue and Market Share by Player (2017-2019)
2.3 Global Hemostatic Agents Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Hemostatic Agents Market Segment Analysis by Type
3.1 Global Hemostatic Agents Market by Type
3.1.1 Gelation Sponge
3.1.2 Oxidized Regenerated Cellulose Based Hemostats
3.1.3 Others
3.2 Global Hemostatic Agents Sales and Market Share by Type (2014-2018)
3.3 Global Hemostatic Agents Revenue and Market Share by Type (2014-2018)
3.4 Global Hemostatic Agents Average Price by Type (2014-2018)
3.5 Leading Players of Hemostatic Agents by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 Hemostatic Agents Market Segment Analysis by Application
4.1 Global Hemostatic Agents Market by Application
4.1.1 Hospitals
4.1.2 Surgical Centers
4.1.3 Nursing Homes
4.2 Global Hemostatic Agents Sales and Market Share by Application (2014-2018)
4.3 Leading Consumers of Hemostatic Agents by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 Hemostatic Agents Market Segment Analysis by Sales Channel
5.1 Global Hemostatic Agents Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Hemostatic Agents Sales and Market Share by Sales Channel (2014-2018)
5.3 Leading Distributors/Dealers of Hemostatic Agents by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Hemostatic Agents Market Segment Analysis by Region
6.1 Global Hemostatic Agents Market Size and CAGR by Region (2014-2026)
6.2 Global Hemostatic Agents Sales and Market Share by Region (2014-2018)
6.3 Global Hemostatic Agents Revenue and Market Share by Region (2014-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Hemostatic Agents Market Share by Type
6.4.3 North America Hemostatic Agents Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Hemostatic Agents Market Share by Type
6.5.3 Europe Hemostatic Agents Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Hemostatic Agents Market Share by Type
6.6.3 Asia-Pacific Hemostatic Agents Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Hemostatic Agents Market Share by Type
6.7.3 South America Hemostatic Agents Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Hemostatic Agents Market Share by Type
6.8.3 Middle East & Africa Hemostatic Agents Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Hemostatic Agents Players
7.1 Ethicon
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Pfizer
7.3 Baxter International
7.4 C. R. Bard
7.5 The Medicines Company
7.6 Anika Therapeutics
7.7 Advanced Medical Solutions
7.8 Integra LifeSciences
7.9 B Braun Melsungen
7.10 Gelita Medical
7.11 Equimedical
7.12 Vascular Solutions
7.13 Marine Polymer Technologies
7.14 Z-Medica
7.15 CryoLife
7.16 BioCer Entwicklungs
7.17 Biom’Up SAS
Chapter 8 Upstream and Downstream Analysis of Hemostatic Agents
8.1 Industrial Chain of Hemostatic Agents
8.2 Upstream of Hemostatic Agents
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Hemostatic Agents
8.3.1 Leading Distributors/Dealers of Hemostatic Agents
8.3.2 Leading Consumers of Hemostatic Agents
Chapter 9 Development Trend of Hemostatic Agents (2019-2028)
9.1 Global Hemostatic Agents Market Size (Sales and Revenue) Forecast (2019-2028)
9.2 Global Hemostatic Agents Market Size and CAGR Forecast by Region (2019-2028)
9.3 Global Hemostatic Agents Market Size and CAGR Forecast by Type (2019-2028)
9.4 Global Hemostatic Agents Market Size and CAGR Forecast by Application (2019-2028)
9.5 Global Hemostatic Agents Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
